Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH). (Q31924252)

5 July 2017

Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH). (English)

1 reference

5 July 2017

1 reference

A Balogh

1

1 reference

5 July 2017

E Kauf

2

1 reference

5 July 2017

R Vollanth

3

1 reference

5 July 2017

G Gräser

4

1 reference

5 July 2017

G Klinger

5

1 reference

5 July 2017

M Oettel

6

1 reference

5 July 2017

language of work or name

1 reference

1 November 2000

1 reference

5 July 2017

1 reference

5 July 2017

62

1 reference

5 July 2017

5

1 reference

5 July 2017

259-269

1 reference

Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay

5 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Pathophysiological and clinical aspects of the insulin-like growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

AP-1-like motif as a key to understanding the insulin-like growth factor I (IGF-I) gene regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Effect of natural menopause on serum levels of IGF-I and IGF-binding proteins: relationship with bone mineral density and lipid metabolism in perimenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Insulin-like growth factor expression in breast cancer epithelium and stroma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Effect of short-term medroxyprogesterone acetate on left ventricular mass: role of insulin-like growth factor-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Insulin-like growth factor I (IGF-I) serum level modifications during transdermal estradiol treatment in postmenopausal women: a possible bimodal effect depending on basal IGF-I values.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Hormonal treatments modulate pulsatile plasma growth hormone, gonadotrophin and osteocalcin levels in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Growth hormone in postmenopausal women after long-term oral estrogen replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Effects of Progestin-Opposed Transdermal Estrogen Administration on Growth Hormone and Insulin-Like Growth Factor-I in Postmenopausal Women of Different Ages*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Effects of aging and dietary restriction on tissue protein synthesis: relationship to plasma insulin-like growth factor-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Altered growth hormone secretion during oral contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Effect of oral contraceptives on adrenocorticotropin and growth hormone secretion following CRH and GHRH administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Growth hormone and somatomedin C during post-menopausal replacement therapy with oestrogen alone and in combination with an antioestrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Alterations in the insulin-like growth factor system during the menstrual cycle in normal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

The response of the growth hormone and insulin-like growth factor I axis to medical castration in women with polycystic ovarian syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Modulatory role of estrogens and progestins on growth hormone episodic release in women with hypothalamic amenorrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900176-1

10.1016/S0010-7824(00)00176-1

7 January 2021

Identifiers

DOI

1 reference

5 July 2017

1 reference